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1. Introduction 
Oxamicetin (l), a new antibiotic isolated recently 
from the fermentation broth of Avthrobacter oxami- 
cetus Tomita and Kawaguchi [2,3], has been shown 
to be a close structural analog to amicetin [4]. It also 
resembles the latter in its antibacterial spectrum, being 
somewhat more active against gram-negative bacteria, 
but less active than amicetin against gram-positive and 
acid-fast bacteria [3]. These structural as well as 
biological similarities strongly suggested that oxamice- 
tin-like amicetin (2), bamicetin (3), gougerotin, and 
blasticidin S - is to be allotted to the aminoacyl-4- 
aminohexosyl-cytosine group of antibiotics [5,6], 
that are all acting upon the acceptor site of both pro- 
karyotic and eukaryotic ribosomes [7]. This paper 
provides confirmatory evidence for this suggestion by 
evaluation of oxamicetin in the fragment reaction and 
fragment binding assays, and, together with the behav- 
iour of some amicetin analogs (4-6) in these systems, 
allows further assessment of steric and functional group 
characteristics as required for inhibitory activity. 
2. Materials and methods 
Ribosomes were prepared from Escherichia coli B, 
as described elsewhere [8]. The transfer of the Ac-Leu- 
residue from the CACCA-Leu-AC fragment to puro- 
mycin was measured according to Monro et al. [9]. 
For assaying the CACCA-Leu-AC binding to the 
donor site, the procedure of Celma et al. [lo] was used, 
whilst the CACCA-Phe binding to the acceptor site 
was determined according to the assay of Pestka [ Ill. 
Oxamicetin (l), in form of its monohydrochloride, 
and amicetin (2) were generous gifts from Dr H. 
Kawaguchi, Bristol-Banyu Research Institute, Tokyo; 
samples of plicacetin (4) cytimidine (5), and cyto- 
samine triacetate (6) were kindly provided by 
Dr T. H. Haskell, Parke-Davis, Ann Arbor, Michigan 
1121. 
* Nucleosides, XXIV. For part XXIII see [ 11. 
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3. Results and discussion 
3.1. Effect of I- 6 on the puromycin reaction with 
CACCA-Leu--Ac as donor substrate 
The effects of the two nucleoside antibiotics (1,2) 
and their structural analogs 3-6 on the 70S-ribosome 
catalyzed A&err-transfer from CACCA-LeuAc to 
puromycin are illustrated in fig.1. In this assay, oxa- 
micetin (1) proved to be a somewhat more potent 
inhibitor of the overall peptidyl transferase activity 
than amicetin (2) but the inhibition course is prac- 
tically identical for both antibiotics. This behaviour 
is similarly exhibited by in vivo screenings with intact 
E. coli bacteria and a number of other test organisms 
[4], thus clearly indicating that the gross antibacterial 
activity of oxamicetin - like amicetin (2) and bami- 
cetin (3) - is due to interaction with the peptidyl- 
transferase centre of the larger ribosomal subunit. 
The analogs (4-6), however, show considerably de- 
creased inhibitory activity. When comparing values at 
50% inhibition (fig. l), plicacetin (4) lacking the (Y- 
methylseryl portion of amicetin and, due to its elabo- 
ration by the amicetin producing organism [ 131 being 
either a degradation product of (2) or the biological 
precursor thereof, is 10 times less active than amicetin. 
This clearly stresses the importance of the aminoacyl 
part, i.e. the presence of ‘structural feature II’ [6] for 
full activity. On the other hand, lossof the disaccharide 
portion in the amicetin molecule has an even more 
profound effect on the AcLeu transfer to puromycin, 
as evidenced by the activity of cytimidine (S), that is 
reduced by a factor of 50. A still poorer inhibitor of 
peptidyl transferase is cytosamine triacetate (6), the 
activity - as compared to amicetin - being reduced by 
two orders of magnitude. 
3.2. Effect of oxamicetin, amicetin and analogs 3-6 
on substrate binding to the donor and acceptor site 
With respect to substrate-interaction at the acceptor 
site, oxamicetin markedly decreased the binding of the 
acceptor substrate (CACCA-Phe) to the acceptor site 
(table 1). Although this effect is slightly weaker than 
in the case of amicetin (cf. table 1) and bamicetin [5], 
it nonetheless suggests a practically identical mode of 
three antibiotics. The analogs (4-6) however, lacking 
either the aminoacid part (9) the disaccharide unit 
(5) or the aminoacyl-aminobenzoic acid portion of 
the amicetin molecule, are nearly devoid of inhibitory 
activity in acceptor substrate binding, the difference 
towards amicetin approaching two orders of magnitude 
(cf. table 1). 
Whilst thus inhibition of the fragment reaction of 
compounds l-6 is paralleled by the inhibitory result 
from acceptor substrate binding, there are some signif- 
icant differences in their interference with the binding 
of the donor substrate. When evaluated for interaction 
with the ethanol-dependent binding of CACCA-Leu- 
AC to 70 S ribosomes, amicetin like bamicetin [5] and 
LO - 
20 - 
Fig.1. The effect of oxamicetin (1, o-o-o), amicetin (2, =-*-a), plicacetin (4, ~-A-A), cytimidine (5, n-o-o) and cytosamine 
triacetate (6, =-m-m) on the fragment reaction of AcLeu-pentanucleotide with puromycin. Reaction mixtures contained ribosomes 
(110 mg protein) and Ac[“C]Leu pentanucleotide (1100 cpm). Log M, concentration of tested compounds (calculated on the 
basis of fmaf volume after addition of methanol). %, AcLeu-puromycin formation as % control without inhibitors (about 800 cpm 
transferred). 
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Table 1 
The effect of oxamicetin, amicetin, cytimidine and of cytosamine triacetate on 
the CACCA- [ “H] Phe and CACCA- [ r ‘C] Leu-AC binding to 70 S ribosomes 
- 
Cont. CACCA-[‘HIPhe CACCA-(“C]Leu 
(mM) cem % cem % 
Control _ 983 100 656 100 
Oxamicetin (1) 0.1 146 76 802 122 
1 532 54 964 147 
3 432 44 1122 171 
Amicetin (2) 0.1 691 70 669 102 
1 314 32 754 115 
3 137 15 750 115 
Cytimidine (5) 1 1017 103 793 121 
3 826 84 1214 185 
10 516 52 
Cytosamine 1 872 89 556 85 
triacetate (6) 3 775 79 532 81 
10 694 70 394 60 
Assay of CACCA-Phe binding was determined according to Pestka [ 111, Reaction 
mixtures containing CACCA-[3H]Phe (4700 cpm) 70 S ribosomes (8 A,,,units) 
and 20% ethanol were incubated at 24°C for 20 min. Assay of CACCA- [’ *Cl Leu- 
AC binding was determined according to Celma et al. (lo]. The incubation mix- 
tures containing CACCA- [’ *Cl Leu-AC (2800 cpm) and 70 S ribosomes 
(11A ,,,tinits) were incubated at 0°C for 60 min. 
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plicacetin [5] exhibit only a very poor increase in 
binding to the donor site (14-17% over control at 
l-3 mM)*. Oxarnicetin, however, and, surprisingly, 
cytimidine as well, had a very pronounced stimulatory 
effect on the donor substrate binding (71 and 85% 
over control at 3 mM), in its size comparable to that 
observed [5] for gougerotin. 
When trying to rationalize this behaviour in terms 
of structure-activity relationships, one is tempted to 
attribute the high stimulatory effect of cytimidine (5) 
to the lack of the bulky disaccharide residue as in 
amicetin, i.e. the presence of a molecule that with 
respect to its major structural features [6] is more 
resembling the strongly stimulating blasticidin S and 
gougerotin than amicetin. Whilst this indeed may be 
* However, when evaluating amicetin in the ethanol-dependent 
binding of CACCA-Leu-Ac to isolated 50 S subunits, the 
stimulation is quite substantial (93% over control at 1 mM) 
[ lo]. This discrepancy may be due to the different bacterial 
strains used (E. coli MRE 600 [lo] versa E. coli B in this 
work), yet a more likely explanation is an apparent differ- 
entiation between 50 S and 70 S particles by amicetin and 
according to 70 S data [5] by bamicetin as well, an effect 
that is only parially exhibited by gougerotin [ 5, lo]. 
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the case, it is on the other hand somewhat startling, 
that introduction of an additional hydroxyl group 
into the disaccharide portion of amicetin (i.e. oxami- 
cetin) causes practically the same increase of donor 
substrate binding as removal of the disaccharide 
portion altogether. Clearly more analogs need to be 
evaluated to unravel these peculiarities. 
Cytosamine triacetate (6) similarly displays some 
exceptional behaviour. Unlike all other antibiotics 
and analogs of this group tested so far, it decreases 
the binding of donor substrate to the donor site of 
peptidyl transferase, e.g. at 10 mM to an extent of 
40%. These characteristics of (6) i.e. inhibition of 
substrate binding to the acceptor as well as to the 
donor site, are reminiscent of the action of macrolide 
antibiotics spiramycin and carbomycin or of lincomy- 
tin [7,10,14], and might point towards an analogy of 
the respective disaccharide units. 
4. Conclusions 
Oxamicetin (l), differing from amicetin (2) by 
an additional hydroxyl group at C-3’ of the disaccharide 
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unit, and, in fact, being a conceivable biosynthetic 
precursor thereof, is somewhat superior to amicetin in 
its inhibitory effect on the fragment reaction and in its 
stimulation of donor substrate binding, whilst substrate 
binding to the acceptor site is slightly lower. These 
effects of (1) and (2), nonetheless, and of bamicetin 
(3) [S] as well, are so closely resembling each other 
as to safely conclude the same mode of action for the 
three antibiotics, i.e. identical sites of interaction with 
the peptidyl transferase centre. Hence, allotment of 
oxamicetin to the aminoacyl4-aminohexosyl-cytosine 
group of ribosomal inhibitors appears to be justified 
structurally as well as biologically. 
When comparing the presently available biological 
data on antibiotics (l-3) with those on the other repre- 
sentatives of this group, i.e. blasticidin S and gougerotin 
there is ample evidence that all are acting upon the 
peptidyl transferase centre of prokaryotic and - in 
less generalizable form - of eukaryotic ribosomes. 
Some minor biological differences among these five 
antibiotics exist nevertheless, most notably between 
amicetin-bamicetin and gougerotin-blasticidin S 
[5,15- 171, indicating that the exact sites of interaction 
within the peptidyl transferase centre are very close 
yet not identical [ 181. Thus, for biological as well as 
for structural reasons, the aminoacyl4-aminohexosyl- 
cytosine group of antibiotics is reasonably subdivided 
into the amicetin group (l-3) featuring the disaccharide 
residue as a unique structural element, and another, i.e. 
blasticidin S-gougerotin, which has the same major 
structural features [6] except the disaccharide unit. 
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